BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19420811)

  • 1. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy.
    Minegishi Y; Takenaka K; Mizutani H; Sudoh J; Noro R; Okano T; Azuma A; Yoshimura A; Ando M; Tsuboi E; Kudoh S; Gemma A
    Intern Med; 2009; 48(9):665-72. PubMed ID: 19420811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias.
    Minegishi Y; Kuribayashi H; Kitamura K; Mizutani H; Kosaihira S; Okano T; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
    J Thorac Oncol; 2011 Apr; 6(4):801-7. PubMed ID: 21336181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Respir Investig; 2023 Mar; 61(2):284-295. PubMed ID: 36496345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias.
    Minegishi Y; Sudoh J; Kuribayasi H; Mizutani H; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
    Lung Cancer; 2011 Jan; 71(1):70-4. PubMed ID: 20493578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
    Kreuter M; Ehlers-Tenenbaum S; Schaaf M; Oltmanns U; Palmowski K; Hoffmann H; Schnabel PA; Heußel CP; Puderbach M; Herth FJ; Warth A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):266-74. PubMed ID: 25591137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Sci Rep; 2024 May; 14(1):10162. PubMed ID: 38702426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
    Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
    PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.
    Fujita T; Hiroishi T; Shikano K; Yanagisawa A; Hayama N; Amano H; Nakamura M; Hirano S; Tabeta H; Nakamura S
    Intern Med; 2018 Jul; 57(13):1827-1832. PubMed ID: 29434143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study.
    Kato M; Yamada T; Kataoka S; Arai Y; Miura K; Ochi Y; Ihara H; Koyama R; Sasaki S; Takahashi K
    Respir Res; 2019 Dec; 20(1):287. PubMed ID: 31852459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema.
    Minegishi Y; Kokuho N; Miura Y; Matsumoto M; Miyanaga A; Noro R; Saito Y; Seike M; Kubota K; Azuma A; Kida K; Gemma A
    Lung Cancer; 2014 Aug; 85(2):258-63. PubMed ID: 24894326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review.
    Chida M; Kobayashi S; Karube Y; Hayama M; Tamura M; Ishihama H; Oyaizu T
    Ann Thorac Cardiovasc Surg; 2012; 18(4):314-7. PubMed ID: 22446955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias.
    Fukui M; Takamochi K; Oh S; Matsunaga T; Suzuki K; Ando K; Suzuki K
    Ann Thorac Surg; 2017 Jun; 103(6):1781-1787. PubMed ID: 28347540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for acute exacerbation of idiopathic interstitial pneumonia in patients undergoing lung cancer treatment.
    Taya T; Chiba H; Yamada G; Takahashi M; Ikeda K; Mori Y; Otsuka M; Takahashi H
    Jpn J Clin Oncol; 2019 Dec; 49(12):1126-1133. PubMed ID: 31411689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbation of idiopathic interstitial pneumonias after surgical resection of lung cancer.
    Kanzaki M; Kikkawa T; Maeda H; Kondo M; Isaka T; Shimizu T; Murasugi M; Onuki T
    Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):16-20. PubMed ID: 21486756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
    Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Edahiro R; Hamasaki T; Inoue Y;
    Respirology; 2019 Jul; 24(7):658-666. PubMed ID: 30835911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia.
    Sand JMB; Tanino Y; Karsdal MA; Nikaido T; Misa K; Sato Y; Togawa R; Wang X; Leeming DJ; Munakata M
    Respir Res; 2018 May; 19(1):82. PubMed ID: 29728109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-2 expression in patients with an acute exacerbation of idiopathic interstitial pneumonias.
    Ando M; Miyazaki E; Abe T; Ehara C; Goto A; Masuda T; Nishio S; Fujisaki H; Yamasue M; Ishii T; Mukai Y; Ito T; Nureki SI; Kumamoto T; Kadota J
    Respir Med; 2016 Aug; 117():27-32. PubMed ID: 27492510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report.
    Taniguchi D; Yamasaki N; Miyazaki T; Tsuchiya T; Matsumoto K; Hatachi G; Kakugawa T; Sakamoto N; Mukae H; Nagayasu T
    Surg Today; 2017 Nov; 47(11):1397-1404. PubMed ID: 28589262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.
    Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Inoue Y
    BMJ Open Respir Res; 2020 May; 7(1):. PubMed ID: 32423894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.